tirzepatide muscle wasting AMRA Used in Analyses Evaluating the Effect on Composition via MRI Does Tirzepatide Cause Muscle Loss?

Semaglutide has transformed diabetes management by lowering blood sugar and A1C levels in clinical trials

A 34-year-old woman with a 23-year history of T1DM presented for review for weight gain (weight 63 kg, BMI 26.9 kg/m2) and increased HbA1c (8.3%) and glycemic variability

Heres what you need to know about the direct implications...

Confirmatory secondary end points included change in 6-minute walk distance, a hierarchical composite end point (death, HF events, and change in KCCQ-CSS and 6-minute walk distance) and change in C-reactive protein

Additionally, novel diagnostic tools, such as corneal confocal microscopy and biomarker-based tests, have improved early detection and intervention

This amount of weight loss has not been accomplished before with medical therapy